Overview

Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Phase III trial to evaluate the efficacy and safety of Genexol®-PM compared to Genexol® in subjects with recurrent or metastatic breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Samyang Biopharmaceuticals Corporation
Treatments:
Paclitaxel